<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref41">
 <mixed-citation publication-type="journal" id="cit41">
  <name>
   <surname>Luo</surname>
   <given-names>D.</given-names>
  </name>; 
  <name>
   <surname>Vasudevan</surname>
   <given-names>S. G.</given-names>
  </name>; 
  <name>
   <surname>Lescar</surname>
   <given-names>J.</given-names>
  </name> (
  <year>2015</year>) 
  <article-title>The flavivirus NS2B–NS3 protease–helicase as a target for antiviral drug development</article-title>. 
  <source>Antiviral Res.</source>
  <volume>118</volume>, 
  <fpage>148</fpage>–
  <lpage>158</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2015.03.014</pub-id>.
  <pub-id pub-id-type="pmid">25842996</pub-id>
 </mixed-citation>
</ref>
